AM Life Science (AMLS) has been engaged by an emerging biotech company in the Northeastern United States to provide validation program development support for obtaining approval of a new drug therapy.
One of our talented team members will serve a critical role in developing sustainable procedures and guidelines to provide the highest levels of quality for new drug products in the current and future pipeline. Currently, the companies are working together to establish robust quality systems to ensure commercial approval of new biologics, including medicine to treat a serious indication that currently has no available drug therapy options.
“We have been in this industry a long time, longer than most. I think it’s our history of working closely with professionals in the field that creates these types of rare and inspiring opportunities.” says Rod Azadan, Head of AM Life Science.
If you need validation support, Contact us today!
